company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,398627000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,398627000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,375497000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,375497000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,23130000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,19331000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19331000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3799000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,512000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-319000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,40000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-791000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3008000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3008000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3008000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3008000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,33142000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33936000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33400000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2013.0,Q3,2013-07-01,2013-09-30,2014-11-25 16:33:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,465677000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,465677000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,436168000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,436168000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29509000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,23539000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23539000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5970000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,530000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-401000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,468000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-463000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5507000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3817000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1690000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1690000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1690000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32044432.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,34935615.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,33800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 17:19:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,541675000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,541675000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,512107000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,512107000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,29568000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,27485000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27485000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2083000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,365000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,648000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,332000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2415000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,740000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1675000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1675000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1675000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,30748750.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33304028.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41900000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q2,2014-04-01,2014-06-30,2015-08-04 16:12:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,595529000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,595529000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,555364000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,555364000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40165000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,34306000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34306000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5859000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,734000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,6539000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4696000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1109000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6968000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2427000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4541000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4541000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4541000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,31643725.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.12
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,33670041.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,37800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 17:20:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.12
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,612075000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,612075000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,571178000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,571178000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,40897000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,42226000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,42226000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1329000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,899000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-3921000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,465000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4355000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5684000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2329000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3355000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3355000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-225000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3130000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36012592.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,38553995.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,39800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.09
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,624883000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,624883000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,583741000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,583741000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,41142000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,36304000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36304000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4838000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,321000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,105000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-216000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4622000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1950000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2672000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2672000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-186000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2858000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,51813464.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,54760853.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47600000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 17:07:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,808011000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,808011000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,738342000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,738342000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,69669000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62474000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62474000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7195000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1903000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,75000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1828000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5367000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2254000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3113000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3113000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-277000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3390000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,62610850.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,64795362.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 17:12:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,946913000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,946913000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,871150000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,871150000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,75763000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,48860000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48860000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26903000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1542000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,90000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1452000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25451000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9768000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15683000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15683000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-278000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15961000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,63890060.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.25
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,65513055.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.24
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,63800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:13:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.25
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,986824000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,986824000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,910159000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,910159000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,76665000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69664000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69664000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7001000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1473000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,38000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1435000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5566000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2262000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3304000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3304000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-263000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3567000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,60730133.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.06
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,63096951.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.07
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,61400000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.06
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,995870000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,995870000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,916632000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,916632000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79238000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54194000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54194000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25044000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1434000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,107000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1327000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23717000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8534000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,15183000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,15183000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-246000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,15429000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,64539161.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67844937.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,64300000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:12:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1088506000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1088506000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1005236000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1005236000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,83270000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,69416000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,69416000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13854000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1521000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,105000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1416000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,12438000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4145000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,8293000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8293000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-241000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8534000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66085149.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68034392.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65600000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q2,2016-04-01,2016-06-30,2017-08-09 16:50:11+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1181173000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1181173000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1102661000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1102661000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,78512000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,77138000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,77138000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1374000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1831000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,49000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1782000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-408000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3236000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2828000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2828000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2580000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5408000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66511118.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.08
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68359611.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.08
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67600000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q3,2016-07-01,2016-09-30,2017-11-06 16:56:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.08
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1144839000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1144839000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1120273000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1120273000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,24566000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,12957000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,4804000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17761000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6805000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1787000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-4659000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,109000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6337000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,468000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1752000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1284000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1284000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-186000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1098000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,65970396.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68047723.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,65800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1078740000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1078740000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,993691000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,993691000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,85049000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,76501000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,76501000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8548000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2049000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,33000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2016000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6532000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2307000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4225000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4225000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-142000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4367000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,66886866.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.07
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67780434.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.06
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,62400000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q1,2017-01-01,2017-03-31,2018-05-08 17:27:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.07
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1126464000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1126464000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1059750000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1059750000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,66714000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,61871000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,61871000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4843000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,1931000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,34000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1897000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2946000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-544000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3490000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3490000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-101000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3591000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67528151.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68211882.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,71800000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q2,2017-04-01,2017-06-30,2018-08-06 17:41:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1124957000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1124957000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1059867000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1059867000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,65090000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,62782000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,62782000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2308000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2054000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,45000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2009000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,299000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-662000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,961000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,961000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-55000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1016000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68371429.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68769618.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,101600000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q3,2017-07-01,2017-09-30,2018-11-06 19:21:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1155069000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1155069000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1097777000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1097777000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,57292000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,54426000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,54426000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2866000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4682000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,101000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4581000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1715000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-8227000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6512000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6512000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-24000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6536000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68130322.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.1
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68780053.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.11
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67400000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.1
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1342484000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1342484000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1252106000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1252106000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,90378000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,81687000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,81687000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8691000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10427000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,418000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10009000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1318000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-868000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-450000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-450000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-450000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45000000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45000000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,73996313000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:06:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1416078000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1416078000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1317662000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1317662000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,98416000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,90642000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,90642000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,7774000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10392000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,394000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9998000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-2224000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1740000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-3964000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-3964000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-3964000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,79300000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,79300000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74158622.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q2,2018-04-01,2018-06-30,2019-08-09 16:02:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.05
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1373334000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1373334000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1279976000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1279976000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93358000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,83419000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,83419000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,9939000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10179000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,288000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-9891000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-121000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,169000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,169000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,169000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74386386.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74741511.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q3,2018-07-01,2018-09-30,2019-11-12 16:06:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1360628000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1360628000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1266771000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1266771000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,93857000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,79902000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,307644000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,387546000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-293689000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10652000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-329000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,856000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10125000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-303814000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5790000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-298024000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-298024000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-298024000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74244520.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-4.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74244520.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-4.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74300000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-4.01
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1256808000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1256808000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1177588000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1177588000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,79220000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,82868000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,82868000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-3648000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10215000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,181000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10034000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13682000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,619000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14301000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14301000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14301000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74460990.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74460990.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74460990.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q1,2019-01-01,2019-03-31,2019-05-10 16:06:40+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1287624000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1287624000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1214897000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1214897000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,72727000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,80816000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,140870000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,221686000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-148959000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10170000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,101000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10069000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-159028000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,434000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-159462000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-159462000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-159462000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74730823.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74730823.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,74730823.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q2,2019-04-01,2019-06-30,2019-08-09 16:02:33+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.13
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1301197000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1301197000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1237812000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1237812000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,63385000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,74993000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,156249000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,231242000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-167857000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11659000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,149000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11510000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-179367000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-2087000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-177280000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-177280000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-177280000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75509088.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.35
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75509088.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.35
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,75400000.0
Diplomat Pharmacy Inc,DPLO,549300JMF6BE0NGN4Q45,0001610092,2019.0,Q3,2019-07-01,2019-09-30,2019-11-12 16:06:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.35
